Literature DB >> 1867633

Human ribonucleotide reductase. Activation and inhibition by analogs of ATP.

J A Harrington1, T Spector.   

Abstract

Sixteen ATP analogs were studied as activators of CDP reduction catalyzed by human ribonucleotide reductase. Activation constants were determined. Three analogs, 3-deazaATP, 5'-adenylimidodiphosphate, and 3'-dATP, activated approximately as efficiently as ATP. Four analogs were partial activators. These seven activators were also accessory activators of GDP reduction. Furthermore, two other analogs, adenosine-5'-O-(1-thiotriphosphate) and 8-bromoATP, selectively stimulated GDP reduction. Ten analogs, at equal molar concentrations with ATP, inhibited ATP-dependent activation of CDP reduction and/or accessory activation of GDP reduction by greater than 45%. No analog inhibited as potently as 2'-dATP, which had an IC50 of 30-50 microM versus the stimulation of CDP and GDP reduction by 2.0 mM ATP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1867633     DOI: 10.1016/0006-2952(91)90033-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  1 in total

Review 1.  Computational studies on class I ribonucleotide reductase: understanding the mechanisms of action and inhibition of a cornerstone enzyme for the treatment of cancer.

Authors:  Susana Pereira; Nuno M F S A Cerqueira; Pedro Alexandrino Fernandes; Maria João Ramos
Journal:  Eur Biophys J       Date:  2005-10-29       Impact factor: 1.733

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.